Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study
Titel:
Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: Safety analyses from the randomized, placebo-controlled, phase III TALAPRO-2 study
Auteur:
Azad, Arun A. Fizazi, Karim Matsubara, Nobuaki Saad, Fred De Giorgi, Ugo Joung, Jae Young Fong, Peter C.C. Jones, Robert J. Zschäbitz, Stefanie Oldenburg, Jan Shore, Neal D. Dunshee, Curtis Carles, Joan Fay, Andre P. Lin, Xun DeAnnuntis, Liza Di Santo, Nicola Zielinski, Michael A. Agarwal, Neeraj